The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)
Abstract
Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X-linked disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which catalyzes a step in the catabolism of glycosaminoglycans. In patients with mucopolysaccharidosis II, glycosaminoglycans accumulate within tissues and organs, contributing to the signs and symptoms of the disease. Mucopolysaccharidosis II affects multiple organs and physiologic systems and has a variable age of onset and variable rate of progression. Common presenting features include excess urinary glycosaminoglycan excretion, facial dysmorphism, organomegaly, joint stiffness and contractures, pulmonary dysfunction, myocardial enlargement and valvular dysfunction, and neurologic involvement. In patients with neurologic involvement, intelligence is impaired, and death usually occurs in the second decade of life, whereas those patients with minimal or no neurologic involvement may survive into adulthood with normal intellectual development. Enzyme replacement therapy has emerged as a new treatment for mucopolysaccharidosis disorders, including Hunter syndrome. The purpose of this report is to provide a concise review of mucopolysaccharidosis II for practitioners with the hope that such information will help identify affected boys earlier in the course of their disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
The frequency of lysosomal storage diseases in The Netherlands
Poorthuis, B. J. H. M., Wevers, R. A., Kleijer, W. J., Groener, J. E. M., de Jong, J. G. N., van Weely, S., Niezen-Koning, K. E., & van Diggelen, O. P. (1999) · Human Genetics · doi:10.1007/s004390051078 · Cited by 720
Muenzer, J., Wraith, J. E., Beck, M., Giugliani, R., Harmatz, P., Eng, C. M., Vellodi, A., Martin, R., Ramaswami, U., Gucsavas-Calikoglu, M., et al. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000232477.37660.fb · Cited by 584
Self-citationWraith, J. E., Clarke, L. A., Beck, M., Kolodny, E. H., Pastores, G. M., Muenzer, J., Rapoport, D. M., Berger, K. I., Swiedler, S. J., Kakkis, E. D., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.046 · Cited by 547
Self-citationIncidence of Inborn Errors of Metabolism in British Columbia, 1969–1996
Applegarth, D. A., Toone, J. R., & Lowry, R. A. R. B. (2000) · Pediatrics · doi:10.1542/peds.105.1.e10 · Cited by 407
Harmatz, P., Giugliani, R., Schwartz, I., Guffon, N., Teles, E. L., Miranda, M. C. S., Wraith, J. E., Beck, M., Arash, L., Scarpa, M., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.014 · Cited by 364
Self-citationThe defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide.
Fratantoni, J. C., Hall, C. W., & Neufeld, E. F. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.60.2.699 · Cited by 310
Mucopolysaccharidoses and the Eye
Ashworth, J. L., Biswas, S., Wraith, E., & Lloyd, I. C. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.11.007 · Cited by 282
A Rare Disease in Two Brothers
Hunter, C. (1917) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591571701001833 · Cited by 280
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
Wilson, P. J., Morris, C. P., Anson, D. S., Occhiodoro, T., Bielicki, J., Clements, P. R., & Hopwood, J. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8531 · Cited by 270
Incidence of the mucopolysaccharidoses in Northern Ireland
Nelson, J. (1997) · Human Genetics · doi:10.1007/s004390050641 · Cited by 229
Gargoylism – A mucopolysaccharidosis
Brante, G. (1952) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365515209060631 · Cited by 228
The mucopolysaccharidoses: a clinical review and guide to management.
Wraith, J. E. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.72.3.263 · Cited by 225
Muenzer, J., Gucsavas-Calikoglu, M., McCandless, S. E., Schuetz, T. J., & Kimura, A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.09.001 · Cited by 223
Self-citationSulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship
Sardiello, M., Annunziata, I., Roma, G., & Ballabio, A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi351 · Cited by 188
Bondeson, M.-L., Dahl, N., Malmgren, H., Kleijer, W. J., Tönnesen, T., Carlberg, B.-M., & Pettersson, U. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.4.615 · Cited by 175
Long‐term follow‐up following bone marrow transplantation for Hunter disease
Vellodi, A., Young, E., Cooper, A., Lidchi, V., Winchester, B., & Wraith, J. E. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005525931994 · Cited by 166
Newborn screening for lysosomal storage disorders
Meikle, P. J., Grasby, D. J., Dean, C. J., Lang, D. L., Bockmann, M., Whittle, A. M., Fietz, M. J., Simonsen, H., Fuller, M., Brooks, D. A., et al. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.02.013 · Cited by 164
Dangel, J. H. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050872 · Cited by 163
Türkmen, S., Gillessen-kaesbach, G., Meinecke, P., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201050 · Cited by 134
Disordered breathing during sleep in patients with mucopolysaccharidoses
Leighton, S. E. J., Papsin, B. C., Vellodi, A., Dinwiddie, R., & Lane, R. (2001) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/s0165-5876(01)00417-7 · Cited by 124
Civallero, G., Michelin, K., de Mari, J. F., Viapiana, M., Burin, M. G., Coelho, J. C., & Giugliani, R. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.029 · Cited by 118
Self-citationNewborn Screening for Lysosomal Storage Disorders: Clinical Evaluation of a Two-Tier Strategy
Meikle, P. J., Ranieri, E., Simonsen, H., Rozaklis, T., Ramsay, S. L., Whitfield, P. D., Fuller, M., Christensen, E., Skovby, F., & Hopwood, J. J. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0583 · Cited by 110
Effect of Leukocyte Transfusion in a Child with Type II Mucopolysaccharidosis
Knudson, A. G., Ferrante, N. D., & Curtis, J. E. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1738 · Cited by 100
Cognitive outcome in urea cycle disorders
Gropman, A. L., & Batshaw, M. L. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.11.016 · Cited by 100
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
Cardone, M., Polito, V. A., Pepe, S., Mann, L., d’Azzo, A., Auricchio, A., Ballabio, A., & Cosma, M. P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl038 · Cited by 100
Muenzer, J. (1986) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00309-8 · Cited by 91
Self-citationMolecular and phenotypic variation in patients with severe Hunter syndrome
Timms, K. M., Bondeson, M.-L., Ansari-Lari, M. A., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.479 · Cited by 80
Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome
Wilson, P., Suthers, G. K., Callen, D. F., Baker, E., Nelson, P., Cooper, A., Wraith, J. E., Sutherland, G., Morris, C. P., & Hopwood, J. J. (1991) · Human Genetics · doi:10.1007/bf00194643 · Cited by 77
Li, P., Bellows, A. B., & Thompson, J. N. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.1.21 · Cited by 62
Mullen, C., Thompson, J. A., Richard, L., & Chan, K. A. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702397 · Cited by 62
Peters, C., & Krivit, W. A. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702398 · Cited by 50
Friso, A., Tomanin, R., Alba, S., Gasparotto, N., Puicher, E. P., Fusco, M., Hortelano, G., Muenzer, J., Marin, O., Zacchello, F., et al. (2005) · Journal of Gene Medicine · doi:10.1002/jgm.790 · Cited by 50
Self-citationBergstrom, S., Jj, Q., Greenstein, R. M., & Ascensão, J. L. (1994) · PubMed · Cited by 43
Ørstavik, K. H., Strømme, P., Ek, J., TORVIK, A., & Skjeldal, O. H. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.10.849 · Cited by 30
Attempted enzyme replacement using human amnion membane implantations in mucopolysaccharidoses
Muenzer, J., Neufeld, E. F., Constantopoulos, G., Caruso, R. C., Kaiser‐Kupfer, M. I., Pikus, A., Danoff, J., Berry, R. R., McDonald, H. D., Thompson, J. N., et al. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800340 · Cited by 22
Self-citationGrouped papules in Hurler-Scheie syndrome
Schiro, J. A., Mallory, S. B., Demmer, L., et al. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90107-3 · Cited by 19
The Mucopolysaccharidoses: Advances in Understanding and Treatment
Lorincz, A. E. (1978) · Pediatric Annals · doi:10.3928/00904481-19780201-06 · Cited by 14
The mucopolysaccharidoses: advances in understanding and treatment.
Ae, L. (1978) · PubMed · Cited by 12
Cited by
Overview of the mucopolysaccharidoses
Muenzer, J. (2011) · Rheumatology · doi:10.1093/rheumatology/ker394 · Cited by 486
Self-citationUllman, J. C., Arguello, A., Getz, J. A., Bhalla, A., Mahon, C. S., Wang, J., Giese, T., Bedard, C., Kim, D. J., Blumenfeld, J. R., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1163 · Cited by 205
Calias, P., Papisov, M., Pan, J., Savioli, N., Belov, V., Huang, Y., Lotterhand, J., Alessandrini, M., Liu, N., Fischman, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030341 · Cited by 133
“, Cambridge, MA) is approved for treatment of certain somatic symptoms of Hunter syndrome but there is no pharmacological therapy for treatment of the neurological manifestations, which can include delayed development and progressive cognitive impairment [27].”
Background
Metadata
- Authors
- Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., Muñoz, V., & Muenzer, J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-02-01
- Volume
- 121
- Issue
- 2
- Pages
- e377-e386
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2034511507
- Cited by
- 314
- References
- 41
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.